Tuesday 13 October 2026
Export CLX’s income statement to Excel — free account
The Clorox Company
CLX Consumer Defensive Household & Personal Products
The Clorox Company’s revenue for fiscal 2026 (year ended June 2026) was $6.7 billion, down 5.41% from fiscal 2025. In the quarter to June 2026, revenue fell 2.01%, EPS fell 50.4%, free cash flow grew 11.4% and total debt rose 60.3%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for twenty-five consecutive years; insiders bought in the last twelve months.
84.35
0.55
+0.66%
Follow CLX
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
19.24 | 16.40 | 16.77 | 19.80 |
P/S ratio |
2.23 | 1.81 | 1.86 | 1.73 | |
P/FCF ratio |
23.77 | 15.76 | 33.10 | 28.70 | |
P/Operating CF |
162.58 | 39.42 | (103.09) | 35.22 | |
P/B ratio |
109.57 | 350.32 | 136.70 | 46.12 | |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Sales |
2.64 | 2.21 | 2.12 | 2.30 | |
EV/EBITDA |
14.30 | 11.90 | 10.96 | 13.33 | |
EV/Operating CF |
20.95 | 15.20 | 24.85 | 25.26 | |
EV/FCF |
28.10 | 19.22 | 37.66 | 38.18 | |
Quick Ratio |
0.39 | 0.38 | 0.59 | 0.34 | |
Current Ratio |
0.76 | 0.74 | 0.84 | 0.66 | |
Net Debt/EBITDA |
12.81 | 7.63 | 3.75 | 11.43 | |
Debt/Assets |
44.95% | 44.29% | 38.64% | 51.09% | |
Debt/Equity |
18.01 | 71.03 | 27.03 | 15.80 | |
Asset Turnover |
1.23 | 1.21 | 1.13 | 1.01 | |
Operating CF/Net income |
1.16 | 1.98 | (0.65) | 2.02 | |
Capex/Depreciation |
(0.64) | (0.76) | (0.74) | (1.10) | |
Interest Coverage |
5.43 | 9.64 | 10.70 | 4.69 | |
Research and Development Expense of Revenue |
1.96% | 1.73% | 1.62% | 1.64% | |
Selling, General and Administrative Expense of Revenue |
31.00% | 27.02% | 24.31% | 26.39% | |
Intangible Assets out of Total Assets |
0.32 | 0.32 | 0.28 | 0.45 | |
Share Based Compensation of Revenue |
0.70% | 1.43% | 0.90% | (0.05%) | |
Graham Net Nets |
(0.24) | (0.31) | (0.29) | (0.49) | |
Graham Number |
12.74 | 6.31 | 10.27 | 14.98 | |
Earnings Yield |
5.20% | 6.10% | 5.96% | 5.05% | |
Free Cash Flow Yield |
4.21% | 6.35% | 3.02% | 3.48% | |
Revenue per Share |
11.65 | 13.76 | 13.76 | 16.00 | |
Operating CF per Share |
0.76 | 2.56 | (1.01) | 2.71 | |
Capex per Share |
(0.29) | (0.35) | (0.35) | (0.71) | |
Free Cash Flow per Share |
0.46 | 2.21 | (1.36) | 2.00 | |
Cash per Share |
1.35 | 1.87 | 9.78 | 1.17 | |
Shareholders Equity per Share |
1.13 | 0.29 | 0.76 | 2.07 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
1.13 | 0.29 | 0.76 | 2.07 | |
Free Cash Flow |
57.00 | 269.00 | (165.00) | 244.00 | |
Working Capital |
(539.00) | (619.00) | (504.00) | (949.00) | |
Capital Expenditures |
(36.00) | (42.00) | (43.00) | (86.00) | |
Net Current Asset Value |
(3,695.00) | (3,850.00) | (3,693.00) | (5,718.00) | |
EV/EBIT |
17.37 | 14.46 | 13.25 | 16.93 | |
Capex to Sales |
0.03 | 0.03 | 0.03 | 0.04 | |
Price to Operating Income |
14.69 | 11.86 | 11.65 | 12.73 | |
| Other line items | |||||
Average Receivables |
649.00 | 637.00 | 634.00 | 806.00 | |
Average Payables |
1,699.50 | 1,708.50 | 1,747.50 | 1,714.00 | |
Average Inventory |
585.50 | 600.00 | 611.50 | 650.00 | |
Average Assets |
5,512.50 | 5,595.00 | 5,974.00 | 6,677.50 | |
Average Common Equity |
181.00 | 78.00 | 141.00 | 367.00 |
Columns are period end dates